SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma strengthens as VAN ECK VIP Emerging buys 21.26 lakh shares

22 Dec 2014 Evaluate

Marksans Pharma is currently trading at Rs. 63.60, up by 1.45 points or 2.33% from its previous closing of Rs. 62.15 on the BSE.

The scrip opened at Rs. 63.00 and has touched a high and low of Rs. 64.90 and Rs. 61.90 respectively. So far 1084186 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 69.35 on 15-Sep-2014 and a 52 week low of Rs. 15.50 on 17-Feb-2014.

Last one week high and low of the scrip stood at Rs. 64.90 and Rs. 50.25 respectively. The current market cap of the company is Rs. 2444.77 crore.

The promoters holding in the company stood at 51.26% while Institutions and Non-Institutions held 7.60% and 41.15% respectively.

VAN ECK VIP Emerging Markets Fund has bought 21.26 lakh shares of Marksans Pharma through the open market route. The shares were purchased on an average price of Rs 61.39 valuing the transaction to Rs 13.05 crore.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.

 

Marksans Pharma Share Price

179.55 -0.95 (-0.53%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×